ISIN | LU0515381027 |
---|---|
Valor Number | 11923354 |
Bloomberg Global ID | BBG001746GZ1 |
Fund Name | CT (Lux) European Growth & Income A GBP |
Fund Provider |
Columbia Threadneedle Investments
Web: www.columbiathreadneedle.com Phone: +352 464 0107 460 E-Mail: Lux-CTenquiries@statestreet.com |
Fund Provider | Columbia Threadneedle Investments |
Representative in Switzerland |
Reyl & Cie S.A. Genève Phone: +41 22 816 80 00 |
Distributor(s) |
Banque Cantonale de Genève Genève 2 Phone: +41 22 317 27 27 |
Asset Class | Bonds |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Portfolio is to achieve long-term capital appreciation and an enhanced level of income by investing in companies listed on one of the European States Stock Exchanges or a regulated market. |
Peculiarities |
Current Price * | 27.56 GBP | 21.11.2024 |
---|---|---|
Previous Price * | 27.39 GBP | 20.11.2024 |
52 Week High * | 28.86 GBP | 30.08.2024 |
52 Week Low * | 24.29 GBP | 28.11.2023 |
NAV * | 27.56 GBP | 21.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 35,572,228 | |
Unit/Share Assets *** | 30,491,448 | |
Trading Information SIX |
YTD Performance | +7.36% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
---|---|---|
YTD Performance (in CHF) | +11.90% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
1 month | -1.36% |
21.10.2024 - 21.11.2024
21.10.2024 21.11.2024 |
3 months | -3.87% |
21.08.2024 - 21.11.2024
21.08.2024 21.11.2024 |
6 months | -2.27% |
21.05.2024 - 21.11.2024
21.05.2024 21.11.2024 |
1 year | +13.18% |
21.11.2023 - 21.11.2024
21.11.2023 21.11.2024 |
2 years | +25.96% |
21.11.2022 - 21.11.2024
21.11.2022 21.11.2024 |
3 years | +18.74% |
22.11.2021 - 21.11.2024
22.11.2021 21.11.2024 |
5 years | +47.14% |
21.11.2019 - 21.11.2024
21.11.2019 21.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novo Nordisk AS Class B | 4.18% | |
---|---|---|
ASML Holding NV | 4.01% | |
SAP SE | 3.52% | |
Intesa Sanpaolo | 3.36% | |
Roche Holding AG | 3.22% | |
M&G PLC Ordinary Shares | 3.08% | |
Deutsche Telekom AG | 2.89% | |
Phoenix Group Holdings PLC | 2.88% | |
Sanofi SA | 2.80% | |
SSE PLC | 2.73% | |
Last data update | 30.09.2024 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 2.00% |
Ongoing Charges *** | 1.82% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |